Let's Move Program for Infants with Cerebral Palsy
Trial Summary
What is the purpose of this trial?
The intervention in this study, Let's Move, is a motor intervention for infants at risk for cerebral palsy. We will test the feasibility and acceptability of the intervention as well as preliminary effectiveness.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Let's Move for infants with cerebral palsy?
Research on similar treatments, like iMOVE therapy, shows that early interventions focusing on motor learning and neurorehabilitation can help improve motor skills in young children with cerebral palsy. These treatments aim to enhance mobility and postural control, which are crucial for development.12345
Is the Let's Move Program for Infants with Cerebral Palsy safe for children?
How is the Let's Move treatment different from other treatments for infants with cerebral palsy?
Research Team
Karen Harpster, PhD, OTR/L
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Eligibility Criteria
This trial is for English-speaking caregivers of preterm infants at risk for cerebral palsy, with severe brain abnormalities on MRI or ultrasound. Infants must be 3-8 months corrected age and have specific motor skill challenges as measured by certain assessments. Those with medical conditions preventing active participation, significant visual deficits, or living remotely from the hospital cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Let's Move intervention administered weekly for 16 weeks, alternating between clinic and home (video telehealth) sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Let's Move (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital Medical Center, Cincinnati
Lead Sponsor
Steve Davis
Children's Hospital Medical Center, Cincinnati
Chief Executive Officer since 2021
MD
Daniel Ostlie
Children's Hospital Medical Center, Cincinnati
Chief Medical Officer
MD from University of North Dakota